Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases

(1) Background: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been the first line therapy for EGFR-mutant lung adenocarcinoma (LAC) patients with brain metastases (BMs). However, the role and the optimal time of brain radiotherapy remains controversial. We aimed to i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yu, Wu, Shenghong, Li, Jing, Liang, Xiaohua, Zhou, Xinli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527103/
https://www.ncbi.nlm.nih.gov/pubmed/37759881
http://dx.doi.org/10.3390/brainsci13091280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527103/
https://www.ncbi.nlm.nih.gov/pubmed/37759881
http://dx.doi.org/10.3390/brainsci13091280

Ejemplares similares